MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 373 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $222,075,000 | +33.4% | 3,682,828 | +1.7% | 0.05% | +25.6% |
| Q1 2016 | $166,443,000 | +0.6% | 3,619,897 | +5.7% | 0.04% | +2.6% |
| Q4 2015 | $165,489,000 | +3.8% | 3,423,440 | -8.7% | 0.04% | -7.3% |
| Q3 2015 | $159,398,000 | -19.8% | 3,750,539 | +115.6% | 0.04% | -14.6% |
| Q2 2015 | $198,658,000 | -6.4% | 1,739,558 | +5.7% | 0.05% | -5.9% |
| Q1 2015 | $212,347,000 | +37.3% | 1,645,208 | +5.9% | 0.05% | +34.2% |
| Q4 2014 | $154,678,000 | +1.8% | 1,552,839 | +1.0% | 0.04% | -11.6% |
| Q3 2014 | $152,008,000 | +32.8% | 1,537,452 | +3.6% | 0.04% | +34.4% |
| Q2 2014 | $114,423,000 | +17.4% | 1,484,468 | -2.0% | 0.03% | +10.3% |
| Q1 2014 | $97,481,000 | +7.8% | 1,514,378 | +6.9% | 0.03% | +3.6% |
| Q4 2013 | $90,435,000 | +11.2% | 1,417,033 | +4.4% | 0.03% | +3.7% |
| Q3 2013 | $81,342,000 | +38.4% | 1,357,050 | +13.6% | 0.03% | +22.7% |
| Q2 2013 | $58,770,000 | – | 1,194,507 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |